Germany News
Most Popular Germany Story
Teva comes out on top with $5B Ratiopharm bid
And the winner is... Teva. This morning, the generics giant announced that it was buying Ratiopharm for just under $5 billion, beating out Pfizer and Actavis for the German company. Ratiopharm is Read more...
Latest Headlines
- December 15, 2011
- November 28, 2011
- October 5, 2011
- September 21, 2011
- September 16, 2011
- September 2, 2011
- July 8, 2011
- June 10, 2011
- February 7, 2011
- November 12, 2010
- October 29, 2010
- September 20, 2010
- June 30, 2010
- June 18, 2010
- May 20, 2010
- April 29, 2010
- March 26, 2010
- March 18, 2010
- March 17, 2010
- March 8, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
